Pacific Biosciences of California, which is developing a system that performs real-time DNA sequencing, will see its quiet period end on Sunday, December 5. On October 26, the company raised $200 million by offering 12.5 million shares at $16, within the range of $15-$17. J.P. Morgan and Morgan Stanley acted as lead managers on the deal.
